These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2577106)

  • 61. Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents.
    Byfield JE; Calabro-Jones PM
    Nature; 1981 Nov; 294(5838):281-3. PubMed ID: 6975441
    [No Abstract]   [Full Text] [Related]  

  • 62. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 63. Novel 1-haloalkyl-2-nitroimidazole bioreductive alkylating agents.
    Heimbrook DC; Shyam K; Sartorelli AC
    Anticancer Drug Des; 1988 Mar; 2(4):339-50. PubMed ID: 3130072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potential alkylating agents derived from benzimidazole and benzothiazole.
    Omar AM; Habib NS; Aboulwafa OM
    J Pharm Sci; 1982 Sep; 71(9):991-3. PubMed ID: 7131285
    [No Abstract]   [Full Text] [Related]  

  • 66. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 67. ALKYLATION OF SYNTHETIC POLYNUCLEOTIDES.
    LUDLUM DB; WARNER RC; WAHBA AJ
    Science; 1964 Jul; 145(3630):397-9. PubMed ID: 14172601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Interaction of alkylating oligonucleotide derivatives with mammalian cells. A study of the uptake mechanism of derivative cells].
    Vlasov VV; Ivanova EM; Kutiavin IV; Raĭt AS; Iurchenko LV
    Mol Biol (Mosk); 1989; 23(1):93-100. PubMed ID: 2739651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cytostatic agents and male fertility].
    Wildschut J; den Ottolander GJ; Hartgrink-Groeneveld CA
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):412-7. PubMed ID: 1250434
    [No Abstract]   [Full Text] [Related]  

  • 70. Studies with alkylating esters. VI. The chemical and biological activities of the isomers of dimethylmyleran.
    Jones AR
    Chem Biol Interact; 1973 Jan; 6(1):47-57. PubMed ID: 4689909
    [No Abstract]   [Full Text] [Related]  

  • 71. Alkylating agents.
    Lind MJ; Thatcher N
    Curr Opin Oncol; 1989 Dec; 1(2):192-7. PubMed ID: 2489959
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 73. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.
    Perez RP; Hamilton TC; Ozols RF
    Pharmacol Ther; 1990; 48(1):19-27. PubMed ID: 2274575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents.
    Tanasova M; Sturla SJ
    Chem Rev; 2012 Jun; 112(6):3578-610. PubMed ID: 22482429
    [No Abstract]   [Full Text] [Related]  

  • 75. 2- and 6-methyl-1,4-naphthoquinone derivatives and potential bioreductive alkylating agents.
    Antonini I; Lin TS; Cosby LA; Dai YR; Sartorelli AC
    J Med Chem; 1982 Jun; 25(6):730-5. PubMed ID: 7097727
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction of chromosomal aberrations and mutations with isomeric forms of L-threitol-I,4-bismethanesulfonate in plant materials.
    Matagne R
    Mutat Res; 1969; 7(2):241-7. PubMed ID: 5796521
    [No Abstract]   [Full Text] [Related]  

  • 77. The anesthetic implications of chemotherapy.
    Ciresi SA
    AANA J; 1983 Feb; 51(1):26-30. PubMed ID: 6858573
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacology and toxicology of chemotherapeutic agents.
    Rodrigues RL
    Emerg Med Clin North Am; 1993 May; 11(2):431-43. PubMed ID: 8491115
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alkylating agents, nitrosoureas and alkyltriazenes.
    Connors TA
    Cancer Chemother Biol Response Modif; 1987; 9():23-35. PubMed ID: 3079405
    [No Abstract]   [Full Text] [Related]  

  • 80. [Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents].
    Winkler A; Ujházy V; Sándor L; Drahovský D
    Cas Lek Cesk; 1966 Sep; 105(39):1068-71. PubMed ID: 5976461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.